NIH Guide: Weekly Index for December 6, 2024

Funding Opportunities

• NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Independent Clinical Trial Not Allowed)
  (PAR-24-317)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Clinical Trial Required)
  (PAR-24-318)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Required)
  (PAR-24-319)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed)
  (PAR-24-320)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
  (PAR-25-188)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Multiple dates, see announcement.
• Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
  (PAR-25-215)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
• Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
  (PAR-25-216)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
• Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
  (PAR-25-265)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
• Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
  (PAR-25-266)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
• NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
  (PAR-25-269)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Multiple dates, see announcement.
• NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
  (PAR-25-270)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Multiple dates, see announcement.
• NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
  (PAR-25-271)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed)
  (PAR-25-300)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Not Applicable
• Artificial Intelligence in Pre-clinical Drug Development for AD/ADRD (R01 Clinical Trial Not Allowed)
  (RFA-AG-24-049)
  National Institute on Aging
  Application Receipt Date(s): February 13, 2025
• Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R01 Clinical Trials Required)
  (RFA-DA-26-003)
  National Institute on Drug Abuse
  Office of Research on Women's Health
  Office of AIDS Research
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Not Applicable
• Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R34 Clinical Trials Required)
  (RFA-DA-26-004)
  National Institute on Drug Abuse
  Office of Research on Women's Health
  Office of AIDS Research
  Application Receipt Date(s): Not Applicable
• Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trials Not Allowed)
  (RFA-ES-25-003)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
• In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed
  (RFA-RM-24-012)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): March 07, 2025